Innovating Pharma's Future With Precision

SGP Care is the industry's only comprehensive pharmaceutical partner offering all 11 essential services under one roof - from 503B compounding to CDMO services, telehealth integration, and regulatory consulting. Unlike competitors who specialize in single services, we provide seamless coordination across the entire pharmaceutical value chain, reducing complexity and costs for our partners.

503A compounding pharmacies produce medications based on individual patient prescriptions for home use, while 503B outsourcing facilities like SGP Care produce larger batches of compounded medications for hospitals, clinics, and healthcare systems. 503B facilities must comply with current Good Manufacturing Practices (cGMP) and undergo regular FDA inspections, ensuring higher quality standards and scalability.

Our Quick fulfillment team can provide critical medications within 24-48 hours. We maintain emergency protocols for essential drugs including epinephrine, morphine, dextrose 10%, and normal saline. Our 24/7 emergency hotline (1-866-565-2225) connects you directly to our crisis response team who can immediately assess your needs and coordinate emergency compounding and delivery.

SGP Care maintains full compliance with FDA regulations including current Good Manufacturing Practices (cGMP), USP 797 for sterile compounding, and USP 795 for non-sterile compounding. We are FDA registered, DEA licensed for controlled substances, DSCSA compliant for drug distribution, and ISO certified. Our facilities undergo regular inspections and we maintain comprehensive quality assurance protocols.

Yes, our CDMO and FDA consultation services provide comprehensive support from Pre-IND through commercial launch. We offer regulatory strategy development, IND/ANDA/NDA submission support, clinical trial material production, and pre-approval inspection preparation. Our experienced regulatory team has helped clients achieve FDA approval 6 months faster than industry average with a 95% success rate.

SGP Care is licensed to operate in all 50 states, providing comprehensive nationwide coverage for pharmaceutical services. Our multi-state licensing includes pharmacy operations, wholesale distribution, and controlled substances handling, ensuring complete compliance regardless of your location or patient population.

Quality is ensured through our comprehensive Quality Management System including: ISO Class 7 and 8 cleanroom environments, automated dispensing systems, real-time environmental monitoring, extensive quality control testing, batch documentation and traceability, and continuous staff training. We maintain a 99.9% quality compliance rate with zero recalls in our operating history.

CDMO timelines vary by project complexity, but typical phases include: Initial assessment and regulatory strategy (2-4 weeks), formulation development (8-16 weeks), clinical trial material production (4-8 weeks), scale-up and tech transfer (8-12 weeks). Our integrated approach reduces overall development time by 40% compared to working with multiple vendors.

Integration is accomplished through our comprehensive API platform that connects with your telehealth system for real-time prescription processing, inventory management, and order tracking. We provide technical support for EMR integration, ePrescribing connectivity, and direct-to-patient delivery coordination. Our integration typically reduces prescription fulfillment time by 70%.

Our peptide services include custom synthesis, high-purity production (99.9%+), GMP-compliant manufacturing, comprehensive analytical testing, stability studies, and complete regulatory documentation. We support both research applications and clinical trial materials with full chain of custody documentation and quality certificates.